Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1

Study Identifier
P15-336
CT.gov Identifier
NCT02629172
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Hepatitis
    • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    N/A - 120 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * HCV genotype 1 patients treated with paritaprevir/ritonavir/ombitasvir in daily practice
    Exclusion Criteria:
    * Patients who have been previously treated with paritaprevir/ritonavir/ombitasvir

    Protocol Summary

    The main objective of this study is to evaluate the safety and effectiveness of paritaprevir/ritonavir/ombitasvir used for patients infected with HCV genotype 1 in daily practice in Japan.

    Study Locations

    Location
    Status
    Location
    Aichi Medical University Hosp /ID# 152220
    Nagakute, Aichi-ken, Japan, 4801195
    Status
    Not applicable
    Location
    Nagoya City University Hospital /ID# 153642
    Nagoya, Aichi-ken, Japan, 467-8602
    Status
    Not applicable
    Location
    Japanese Red Cross Narita Hosp /ID# 155894
    Narita-shi, Chiba, Japan, 286-8523
    Status
    Not applicable
    Location
    Kikkoman General Hospital /ID# 152139
    Noda, Chiba, Japan, 278-0005
    Status
    Not applicable
    Location
    Matsuyama Red Cross Hosp /ID# 152271
    Matsuyama, Ehime, Japan, 7900826
    Status
    Not applicable
    Location
    NHO Kyushu Medical Center /ID# 153001
    Fukuoka, Fukuoka, Japan, 810-8563
    Status
    Not applicable
    Showing {first} - {last} of {total} Results